Welcome to our dedicated page for USANA Health Sciences news (Ticker: USNA), a resource for investors and traders seeking the latest updates and insights on USANA Health Sciences stock.
USANA Health Sciences Inc (NYSE: USNA) is a U.S.-based company that specializes in developing, manufacturing, and distributing science-backed nutritional and personal-care products. Founded in 1992 by the internationally recognized microbiologist and immunologist, Dr. Myron Wentz, USANA is committed to enhancing the well-being of its customers through high-quality health products. The company operates primarily through a network marketing model, providing rewarding financial opportunities for its independent associates, shareholders, and employees.
USANA's product lines are comprehensive and diverse, catering to various health and nutritional needs. The Essentials line includes core vitamin and mineral supplements. Optimizers offer targeted supplements for specific health requirements. The Foods line features low-glycemic meal replacement shakes and snack bars, promoting balanced nutrition. Sense Beautiful Science offers personal-care products designed for skin and hair health. These products are developed and manufactured in top-notch facilities, ensuring the highest standards of quality and efficacy.
The company's influence extends globally, with operations in Asia-Pacific, the Americas, and Europe. USANA's commitment to innovation is reflected in their proprietary technologies, such as the award-winning InCelligence Technology™ used in their products. Recent achievements include multiple awards at the Korea Medical Healthcare Awards, where USANA's HealthPak and Nutrimeal Active were recognized for their excellence in the multivitamin and weight management categories, respectively.
USANA emphasizes continuous learning and personal growth, as highlighted by their leadership's advocacy for a growth mindset and self-care initiatives. Kevin Guest, the executive chairman of USANA, frequently shares insights that underline the importance of personal development and community contribution. For instance, during Leap Day 2024, Guest proposed seven strategies for making the most of the extra day, ranging from meditation to volunteering.
Moreover, USANA’s financial health and operational integrity have been robust, thanks to their clear communication and strong relationships with customers and distributors across 25 countries. Their dedication to quality and excellence has earned them a solid reputation, making USANA a trusted name in health and wellness. To learn more about their latest products and initiatives, visit their official website at USANA.com.
USANA Health Sciences (NYSE: USNA) earned two awards at the 2023 Korea Medical Healthcare Awards, held on April 20, 2023, in Seoul. Recognized for its HealthPak in the multivitamin category and Nutrimeal Active in the food weight-management category, these accolades highlight USANA's commitment to innovative health solutions.
For five consecutive years, HealthPak has been awarded for its comprehensive nutrient profile, including 14 vitamins, 9 minerals, and 7 botanicals, promoting cellular health. Nutrimeal Active also won recognition for the third year, offering a balanced meal option rich in protein and low in sugar.
The awards reflect USANA’s ongoing dedication to providing quality nutritional products, with plans to maintain its leadership position in the health industry.
USANA Health Sciences, Inc. (NYSE:USNA) announced its first quarter results will be released after market close on April 25, 2023. Following this, a Management Commentary document will be available on the company's Investor Relations website. An analyst conference call is scheduled for April 26, 2023, at 11:00 a.m. Eastern Time, which will be broadcast online. USANA specializes in the development and manufacturing of high-quality nutritional supplements, healthy foods, and personal care products sold primarily in markets including the United States, Canada, Australia, and Hong Kong. More information is accessible at USANA's Investor Relations.
On April 3, 2023, Kevin Guest, CEO of USANA Health Sciences (NYSE: USNA), celebrates International Guitar Month by advocating for harmony in life through music. Guest, a musician and author of All the Right Reasons, 12 Timeless Principles for Living a Life in Harmony, emphasizes the productivity and happiness that comes from living in alignment with core values. He cites five benefits of music: reduced stress, improved mood, better sleep, increased concentration, and enhanced creativity. Each book sold provides 40 meals to hungry children, reinforcing USANA's commitment to social responsibility.
USANA Hong Kong Receives Recognition from Euromonitor International
On March 29, 2023, USANA Hong Kong was named the top brand for calcium supplements by Euromonitor International. The accolade is based on retail value sales data for USANA’s MagneCal D supplement, highlighting its strong market performance. Regional VP Vivienne Lee expressed gratitude for customer support, emphasizing the company's commitment to quality. Philip Tang, general manager, noted this award reflects USANA's vision of promoting health. The recognition positions USANA favorably in the competitive nutritional supplement sector in Hong Kong.
USANA Health Sciences, Inc. (NYSE:USNA), a leader in nutritional supplements, has announced that CFO Doug Hekking will participate in investor conferences. Key events include the 35th Annual Roth Conference in Dana Point, CA on March 13, 2023, and the D.A. Davidson Consumer Growth Conference in New York, NY on March 21, 2023, with a presentation scheduled for 1:15 PM EDT.
Webcasts for these conferences will be accessible via the 'IR Calendar' section of USANA's website. USANA offers a range of high-quality health products sold directly to customers in various countries, including the U.S., Canada, and Australia.
USANA Health Sciences, Inc. congratulates Jessica Arias, the executive director of marketing, on being named to Utah Business magazine's 40 Under 40 list on February 23, 2023. Jessica leads USANA's global marketing efforts, significantly contributing to successful product launches across 24 markets. Her leadership is highlighted by peers, with commendations from Dan Macuga and Ashley Collins, emphasizing her dedication and impact within the company. The Utah Business award recognizes outstanding young professionals who have achieved notable success.
USANA Health Sciences, Inc. (NYSE: USNA) has announced a leadership transition, effective July 1, 2023. Kevin Guest, CEO since 2015, will become Executive Chairman, while Jim Brown, previously President, will take over as CEO. Guest expressed gratitude for his team and confidence in Brown's leadership qualities. Brown emphasized his commitment to advancing USANA’s mission and expanding its market presence. The Board recognizes Guest’s contributions and believes this transition positions USANA for continued growth and success in the health and wellness sector.
USANA Health Sciences, Inc. (USNA) reported its financial results for the fourth quarter and fiscal year 2022, showing a fourth-quarter net sales decline to $228 million from $267 million year-over-year. Q4 diluted EPS fell to $0.66 from $1.03. Full year net sales were $999 million, down 16% from $1,186 million in 2021, with diluted EPS declining 37% to $3.59. The company reiterated its FY 2023 outlook, projecting net sales between $850 million to $950 million and diluted EPS of $2.35 to $3.30.
The active customer base was 490,000, a 13% decrease from the previous year.
FAQ
What is the current stock price of USANA Health Sciences (USNA)?
What is the market cap of USANA Health Sciences (USNA)?
What is USANA Health Sciences?
When was USANA founded?
What are USANA's main product lines?
How does USANA distribute its products?
What recent awards has USANA won?
What is USANA's InCelligence Technology?
Who is Kevin Guest?
Where does USANA operate?
What is USANA's mission?
How can I learn more about USANA's products?
